Monte Rosa Therapeutics, Inc. (GLUE) Earnings
|
Expand Research on GLUE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +50.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/26  |
Q425 | N/A | -$0.33 | N/A | N/A | $15.55M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | $0.00 | -$0.36 | +$0.36 | $12.77M | $7.77M | N/A |  | | Details | |
| 8/7/25 | Q225 | $0.00 | -$0.38 | +$0.38 | $23.19M | $6.33M | N/A | | | Details | |
| 5/8/25 | Q125 | $0.00 | -$0.44 | +$0.44 | $84.93M | $4.91M | N/A | | | Details | |
| 3/20/25 | Q424 | $0.00 | $0.18 | -$0.18 | $60.64M | $51.19M | N/A | | | Details | |
| 11/7/24 | Q324 | -$0.29 | -$0.47 | +$0.18 | $9.22M | $2.61M | N/A | | | Details | |
| 8/8/24 | Q224 | -$0.43 | -$0.53 | +$0.10 | $4.69M | $1.35M | N/A | | | Details | |
| 5/9/24 | Q124 | -$0.53 | -$0.59 | +$0.06 | $1.06M | $1.05M | N/A | | | Details |
